Author

Yesenia C. Lopez

Observed name: Yesenia Lopez

Institution: Grifols (United States)

Observed institutions: University of California, San Francisco, Grifols (United States), Alkahest, Inc. (United States)

ORCID: 0000-0001-6209-7491

Observed ORCID: 0000-0001-6209-7491

OpenAlex ID: A5049088601

Virally encoded connectivity transgenic overlay RNA sequencing (VECTORseq) defines projection neurons involved in sensorimotor integration

2021 · Victoria Cheung, Philip Chung, et al. · Cell Reports · 21

CCR3 plays a role in murine age-related cognitive changes and T-cell infiltration into the brain

2023 · Sanket V. Rege, Arnaud Teichert, et al. · Communications Biology · 20

OS-074 Recombinant polyclonal antibody GIGA-2339 potently neutralizes hepatitis B and hepatitis D virus

2025 · Sheila Keating, Brett Higgins, et al. · Journal of Hepatology · 2

Recombinant polyclonal antibody GIGA-2339 potently and pan-genotypically neutralizes hepatitis B virus

2026 · Sheila M. Keating, Brett W. Higgins, et al. · Antiviral Research

CCR3 inhibition suppresses inflammation-driven recruitment of peripheral immune cells to the eye

2023 · Yesenia Lopez, Sofia Caryotakis, et al. · bioRxiv (Cold Spring Harbor Laboratory)

Determining the pharmacokinetics and ocular distribution of AKST4290, a clinical stage oral therapeutic for age-related macular degeneration

2021 · Yesenia Lopez, Reema Harish, et al. · Investigative Ophthalmology & Visual Science

CCR3 inhibition reduces recruitment of peripheral immune cells to the eye in the sodium iodate model of age-related macular degeneration

2021 · Onkar S. Dhande, Sofia E. Caryotakis, et al. · Investigative Ophthalmology & Visual Science

Works count: 7

Citation count: 43

H-index: 2

I10-index: 2